Litcius/Paper detail

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative

Romain Cohen, Dewi Vernerey, Carine Bellera, Aurélia Meurisse, Julie Henriques, Xavier Paolettí, Benoı̂t Rousseau, Steven Alberts, T. Aparicio, Ioannis Boukovinas, Sharlene Gill, Richard M. Goldberg, Axel Grothey, Tetsuya Hamaguchi, Timothy Iveson, Rachel Kerr, Roberto Labianca, Sara Lonardi, Jeffrey A. Meyerhardt, James Paul, Cornelis J. A. Punt, Leonard B. Saltz, Marck P. Saunders, Hans‐Joachim Schmoll, Manish A. Shah, Alberto Sobrero, Ioannis Souglakos, Julien Taı̈eb, Atsuo Takashima, Dorothea Wagner, Marc Ychou, Franck Bonnetain, Sophie Gourgou, Takayuki Yoshino, Greg Yothers, Aimery de Gramont, Qian Shi, Thierry André

2020European Journal of Cancer33 citationsDOIOpen Access PDF

Topics & Concepts

MedicineClinical endpointColorectal cancerRandomized controlled trialEvent (particle physics)Surrogate endpointDelphi methodCancerInternal medicineOncologyStatisticsPhysicsQuantum mechanicsMathematicsColorectal Cancer Surgical TreatmentsColorectal Cancer Screening and DetectionGenetic factors in colorectal cancer
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative | Litcius